What is CareDx?
Founded in 1998 and headquartered in South San Francisco, California, CareDx operates at the intersection of precision medicine and transplant care. The company is dedicated to the discovery, development, and commercialization of clinically differentiated healthcare solutions. CareDx's offerings span the entire transplant patient journey, encompassing testing services, innovative products, and digital healthcare solutions. By providing genomics-based information, CareDx aims to enhance outcomes for transplant recipients and their caregivers, positioning itself as a key player in a specialized segment of the healthcare industry.
How much funding has CareDx raised?
CareDx has raised a total of $98.5M across 5 funding rounds:
Debt
$6M
Debt
$12.5M
Debt
$15M
Stock Offering
$40M
Debt
$25M
Debt (2010): $6M, investors not publicly disclosed
Debt (2011): $12.5M led by GE Capital Healthcare Financial Services
Debt (2012): $15M supported by Silicon Valley Bank and Oxford Finance Corporation
Stock Issuance/Offering (2014): $40M, investors not publicly disclosed
Debt (2017): $25M, investors not publicly disclosed
Key Investors in CareDx
Silicon Valley Bank
Silicon Valley Bank is a commercial and private banking institution that provides a range of financial services, including investment services, to technology and life science companies. Its involvement suggests a focus on supporting growth-stage companies in innovative sectors.
Oxford Finance Corporation
Oxford Finance Corporation is a specialty finance firm offering financial solutions to healthcare and life sciences companies worldwide. Their participation indicates a strategic alignment with CareDx's mission in the medical field.
GE Capital Healthcare Financial Services
GE Capital's healthcare financial services arm provides investment advisory and financial solutions tailored for the healthcare industry. Their backing of CareDx highlights the company's significant potential within the medical finance landscape.
What's next for CareDx?
The recent major strategic investment in CareDx signals a phase of accelerated growth and potential expansion of its service offerings. With a focus on precision medicine for transplant patients, the company is well-positioned to leverage this capital for further research and development, enhancing its diagnostic capabilities and digital platforms. This strategic backing is likely to fuel advancements in personalized healthcare solutions, solidifying CareDx's role in improving patient care and outcomes within the transplant community.
See full CareDx company page
